CMR, Telecom Information, ET Telecom


NEW DELHI: Shipments within the India pill market grew 4% year-on-year in CY2021, led by Lenovo, Cybermedia Analysis (CMR) mentioned on Thursday. It now expects shipments to hover round 5-10% in CY2022.

Lenovo topped the India pill market in 2021 with a market share of 46% (by shipments), adopted by Apple (20%), Samsung (18%), and Realme (6%), in line with the analysis agency.

Commenting on distributors’ efficiency, CMR mentioned Lenovo’s efficiency was pushed by its enterprise pill enterprise, and its shipments grew remarkably at 23% year-on-year.

Apple within the second place logged a progress of 29% year-on-year in iPad shipments.

Third-placed Samsung, in the meantime, noticed a decline of 36% in its shipments whereas, Realme in fourth place made an “spectacular debut within the pill market”.

India tablet market grows 4% in CY2021, led by Lenovo: CMR

CMR mentioned the general pill market grew 31% on an annual foundation in This autumn, whereas 4G tablets shipments grew sequentially by 2% year-on-year in the identical quarter.

“Pushed by the pandemic, and the necessity for companion gadgets at house for work, be taught and unwind, tablets continued to witness a powerful progress momentum for the second 12 months in succession,” in line with Menka Kumari, Analyst-Business Intelligence Group (IIG), CMR.

The analysis agency tasks the primary quarter of 2022 (January-March) to stay flat year-on-year owing to a low seasonal demand and a gentle influence of the continued Covid-19 pandemic, which can enable model to replenish their inventories whereas 4G to 5G migration will proceed to drive progress “although nonetheless restricted to mid and high-tier worth segments”.

Menka added that the festive season gross sales additionally contributed to the expansion momentum. “Past the B2C section, the B2B pill section additionally noticed a powerful uptick, particularly in healthcare and digital schooling, amongst others.” Going ahead, CMR estimates progress in Q1 2022 to stay slower than projected as a consequence of supply-side constraints.

“In CY2022, we anticipate the pill market to begin on a muted be aware owing to provide constraints. On the demand facet, we anticipate customers to carry onto their new tablets, and this in flip, could pose progress challenges,” Menka mentioned.

The analysis agency forecasts that the enterprise B2B pill section for utilized industrial use instances will “take off”.



Supply hyperlink